Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 8
Submit an article Journal homepage
2,297
Views
1
CrossRef citations to date
0
Altmetric
Diabetes

Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab Emirates

Signe Baattrup Reitzela Department of Economics, EY Denmark, Frederiksberg, DenmarkORCID Iconhttps://orcid.org/0000-0002-2839-4510
ORCID Icon,
Mette Bøgelunda Department of Economics, EY Denmark, Frederiksberg, DenmarkORCID Iconhttps://orcid.org/0000-0003-0866-9414
ORCID Icon,
Amaury Basseb Middle East & Africa, Novo Nordisk Region South East Europe, Zurich, SwitzerlandORCID Iconhttps://orcid.org/0009-0006-2412-8799
ORCID Icon,
Olga Barszczewskab Middle East & Africa, Novo Nordisk Region South East Europe, Zurich, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-5953-7414
ORCID Icon &
Hongye Renc Middle East & Africa, Novo Nordisk Region North West Europe, Copenhagen S, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0080-4765
ORCID Icon
Pages 1055-1060 | Received 01 Jun 2023, Accepted 27 Jun 2023, Published online: 10 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.